The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of study of bevacizumab (BEV) in combination with atezolizumab (ATEZO) in pts (pts) with untreated melanoma brain metastases (BEAT-MBM).
 
Gustavo Schvartsman
Speakers' Bureau - Bristol-Myers Squibb; United Medical
 
Isabella Claudia Glitza
Travel, Accommodations, Expenses - Lilly
 
Denai Milton
No Relationships to Disclose
 
Rodabe Navroze Amaria
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
 
Patrick Hwu
Stock and Other Ownership Interests - Immatics; Iovance Biotherapeutics
Consulting or Advisory Role - Dragonfly Therapeutics; GlaxoSmithKline; Immatics; Iovance Biotherapeutics; Sanofi
Research Funding - Genentech (Inst)
 
Wen-Jen Hwu
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck/Schering Plough
 
Adi Diab
Consulting or Advisory Role - Celgene; CureVac; Nektar
Research Funding - Celgene (Inst); Idera (Inst); Nektar (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Nektar
 
Michael K.K. Wong
Consulting or Advisory Role - Merck; Pfizer
 
Sapna Pradyuman Patel
Stock and Other Ownership Interests - Provectus
Honoraria - PCME, Rockpointe; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Cardinal Health; Castle Biosciences; Incyte
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Castle Biosciences; Incyte; Massachusetts General Hospital; PCME, Rockpointe; Socrates Analytics
 
Jeffrey Scott Wefel
Consulting or Advisory Role - Angiochem; Bayer; Cogstate; Genentech/Roche; Insys Therapeutics; Juno Therapeutics; Novocure; Vanquish Oncology
 
Elizabeth M. Burton
No Relationships to Disclose
 
Courtney Brown
No Relationships to Disclose
 
Scott Eric Woodman
No Relationships to Disclose
 
Ingrid M. Beosch
No Relationships to Disclose
 
Caroline Chung
No Relationships to Disclose
 
Michael A. Davies
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; NanoString Technologies; Novartis; Sanofi; Syndax; Vaccinex
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Hussein Abdul-Hassan Tawbi
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst)